From TADS and SOFTADS to TORDIA and beyond: what's new in the treatment of adolescent depression?

Curr Psychiatry Rep. 2010 Apr;12(2):88-95. doi: 10.1007/s11920-010-0094-x.

Abstract

Major depressive disorder in adolescents is associated with significant morbidity and mortality. Major advances have been made in recent years in the treatment of adolescent depression, with promising outcomes. However, limitations of currently available treatments have prompted attempts to better understand pediatric depression from a broader perspective and to develop more effective treatment strategies in the future.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Adolescent
  • Antidepressive Agents / therapeutic use*
  • Clinical Trials as Topic
  • Cognitive Behavioral Therapy*
  • Combined Modality Therapy
  • Depressive Disorder, Major / diagnosis
  • Depressive Disorder, Major / therapy*
  • Female
  • Fluoxetine / therapeutic use
  • Humans
  • Male
  • Treatment Outcome

Substances

  • Antidepressive Agents
  • Fluoxetine